Nova StatStrip Glucose Bibliography®

Point-of-care glucose testing can be challenging in the hospital setting. Interfering substancessuch as hematocrit, drugs, and elevation of pathophysiological and other endogenous metabolites
have all been shown to interfere with the measurement of glucose testing. Nova’s StatStrip glucose
monitoring system is designed to measure and eliminate the effects of abnormal hematocrit,electrochemical interferences, and endogenous metabolites to provide accurate results.
The following list of citations are from peer-reviewed publications and presentations deliveredat national and international meetings where the performance of StatStrip Glucose has been
evaluated in a variety of critical care settings and diverse patient populations.
Over 200 studies of analytical performance have been published to date. No clinical interferences
have been found.
These studies were conducted at some of the most prestigious hospitals and diabetes centers in
the world and prove that Nova Biomedical’s StatStrip glucose sensor technology significantly
improves accuracy by eliminating hematocrit and other interferences.
Study sites include many highly respected names in the medical community:• Mayo Clinic College of Medicine, Rochester, Minnesota• The Johns Hopkins University School of Medicine, Baltimore, Maryland• University of Toronto Sunnybrook Health Sciences Centre, Toronto, Canada• Addenbrook’s Hospital, Cambridge University Hospitals, United Kingdom• University Hospital of Wales, Cardiff, Wales• Isala Klinieken, Zwolle, Netherlands; Saint-Pierre Hospital, Brussels, Belgium• Saitama Medical University, Saitama, Japan.

Table of Contents

		Background............................................................................... 1
		 Adult Critical and Intensive.................................................... 2
		 Adult Clinical............................................................................ 5
		 Neonatal Critical and Intensive............................................... 6
		 Neonatal and Pediatric Clinical............................................... 7
		Diabetes...................................................................................... 8
		Dialysis....................................................................................... 9
		Analytical................................................................................. 10

Adult Critical and Intensive

1. Bhansali D, Chima HS, Peretti AR, Ramarajan V. Comparative testing for better glycemic control. Lab Medicine.
2009;40:478–481. doi:10.1309/LMGKXR9UY79FRKFS
2. Calderwood R, Bailie R, McBride P, Scott K, Ryan M. Impact of analytical performance of point of care (POCT)
blood glucose meters on application of a ‘tight glycaemic control’(TGC) protocol in an intensive care unit setting.
Poster session presented at the meeting of the European Congress of Clinical Chemistry and Laboratory Medicine,
Berlin, Germany, May 2011.
3. Castaño López MÁ, Fernández de Liger Serrano JL, Robles Rodríguez JL, Márquez Márquez T. Validationof a glucose meter at an intensive care unit. Endocrinología y Nutrición. 2012;59:28–34. doi:10.1016/
jendoen.2011.08.003
4. Chan PC, Rozmanc M, Seiden-Long I, Kwan J. Evaluation of a point-of-care glucose meter for general use incomplex tertiary care facilities. Clinical Biochemistry. 2009;42:1104–1112. doi:10.1016/j.clinbiochem.2009.03.023
		• Poster session presented at the American Association of Clinical Chemistry, Critical and Point-of-Care Testing,
Barcelona, Spain, September 2008

5. Chan PC, Rozmanc M, Seiden-Long I, Kwan J. Evaluation of a point-of-care glucose meter for general use incomplex tertiary care facilities. Clinical Biochemistry. 2009;42:1104–1112. doi:10.1016/j.clinbiochem.2009.03.023
6. Comparison of the Nova Biomedical StatStrip Glucose Meter to an Isotope Dilution Mass Spectrometry Hexokinase
Glucose Method in Oncology and Renal - Insufficient Patients: Demonstration of Utility in Critically Ill Patients.
2015 Diabetes Technology Meeting Abstracts, Journal of Diabetes Science and Technology. 2016;10(2):476-611.
doi:10.1177/1932296816639698
7. Creed GM, Fox TJ, Beale RJ. (2011). Point-of-care glucose monitoring in a critical care setting: Evaluation of a new
maltose independent chemistry Accu-Chek INFORM II, Nova StatStrip, and Abbott Medisense PXP. Point of Care.
2011;10:7–16. doi:10.1097/POC.0b013e318207813b
8. Creed GM. Can a new level of clinical accuracy be achieved with POC glucose meters in an ICU setting?
Poster session presented at the meeting of the European Society of Intensive Care Medicine, Vienna, Austria,
October 2009.
9. Creed GM. Nova StatStrip®: Could this device be used to effectively implement tight glycaemic control andtriage blood glucose and insulin management in critical illness (device evaluation compared to Roche Cobas b221
reference methodology)? Poster session presented at the meeting of the European Congress of Clinical Chemistry
and Laboratory Medicine, Innsbruck, Austria, June 2009.
10. Dubois J et al. Bedside Glucose Monitoring—Is it Safe? A New, Regulatory-Compliant Risk Assessment
Evaluation Protocol in Critically Ill Patient Care Settings. Crit Care Med 2017;45:567-574. doi: 10.1097/
CCM.0000000000002252.
11. DuBois J A, Malic A. “The StatStrip Glucose Hospital Meter System. Point-of-Care Testing in Critically Ill
Patients.” Point of Care. 2017;16,1:51-54.
12. DuBois JA, Lyon ME, Lyon AW, Slingerland RJ, Fokkert M, Roman A, Sartori D. et al. Comparison of four models
for assessing insulin dosing error when a blood glucose monitoring system is used in various patient populations.
Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Point-ofCare Testing Division, San Diego, CA, September 2014.
13. DuBois JA, Malic A. “Off-Label” Use of Blood Glucose Monitoring Systems in Critically Ill Patients. Medical
Laboratory Observer. 2017;49,7:67-69.
14. DuBois, JA. The FDA Reviews Guidelines for Capillary Glucose Testing in Critically Ill Patients. Medical
Laboratory Observer. 2018;50,7:50-53.
15. Fokkert M, Slootstra J, Dollamoursid R, Witteveen C, Muller W, Slingerland R. Traceability and accuracy evaluationof POC StatStrip glucose meter and ABL 835 blood gas analyzer to a primary ID-GCMS aligned reference
measurement procedure. Poster session presented at the meeting of the American Association for Clinical Chemistry,
Critical and Point-of-Care Testing Division, San Diego, CA, September 2014.
2

16. Germagnoli L, Bonini P, DuBois JA, Bierens de Haan J, Tartarotti C. Suitability assessment of a new bedsideinterference free glucose system for use in critical care when compared to current technology. Poster session
presented at the meeting of the American Association for Clinical Chemistry, Critical and Point-of-Care Testing
Division, Barcelona, Spain, September 2008.
17. Germagnoli L, Bonini P, DuBois JA, Bierens de Haan J, Tartarotti C. Suitability assessment of a new bedsideinterference-free glucose system for use in critical care when compared with current technology. Point of Care.
2019;8:96–100. doi:10.1097/POC.0b013e3181b19170
18. Godwin Z, Bockhold J, Bomze L, Tran N. Hematocrit effects leads to inadequate glycemic control and insulin
dosing in adult burn patients. Poster session presented at the meeting of the American Association for Clinical
Chemistry, Los Angeles, CA, July 2012.
19. Hikasa Y, Egi M, Kimura S, Nishie H, Morita K. Reliability of blood glucose measurement using a novel point-ofcare glucometer (StatStrip) in postoperative critically ill patients. 2012.
20. Hopf S, Graf B, Gruber M. Comparison of point-of-care testing glucose results from intensive care patientsmeasured with network-ready devices. Diabetes Technology & Therapeutics. 2011;13:1047–1056. doi:10.1089/
dia.2011.0051
21. Ivanov A. The Nova StatStrip glucose meter evaluation in intensive care unit. Poster session presented at the meetingof the American Association for Clinical Chemistry, Los Angeles, CA, July 2012.
22. Kaneda T, Urimoto G, Ando A, Kan T, Suzuki T. Evaluation of the accuracy of new glucose meter during
cardiopulmonary bypass in open h[e]art surgery. Poster session presented at the meeting of the Anesthesiology
Annual Meeting, October 2010.
23. Kaneda T, Urimoto G, Suzuki T. Interference by some drugs used during cardiopulmonary-bypass (CPB) in open
heart surgery on three glucose measurement devices. Poster session presented at the meeting of the American Societyof Anesthesiologists, Chicago, IL, October 2011.
24. Karon BS, Blanshan CT, Deobald GR, Wockenfus AM. Retrospective evaluation of the accuracy of Roche
AccuChek Inform and Nova StatStrip glucose meters when used on critically ill patients. Diabetes Technology &Therapeutics. 2014;16(12):828-832. doi:10.1089/dia.2014.0074
25. Karon BS, Bryant SK. Impact of glucose meter accuracy on the efficacy of glycemic control in critically ill patients
after cardiovascular surgery. Poster session presented at the meeting of the American Association for Clinical
Chemistry, Critical and Point-of-Care Testing Division, San Diego, CA, September 2014.
26. Karon BS, Donato LJ, Larsen CM, Siebenaler LK, Wells AE, Wood-Wentz CM, Shirk-Marienau ME, Curry TB.
Accuracy of Capillary and Arterial Whole Blood Glucose Measurements Using a Glucose Meter in Patients under
General Anesthesia in the Operating Room. Anesthesiology. 2017;127,3:466-74.
27. Karon BS, Koch CD, Wockenfus AM, Brown JK. Accuracy of whole blood glucose measurement when venous
catheter blood samples are used on glucose meters. Diabetes Technology & Therapeutics. 2009;11:819–825.
doi:10.1089/dia.2009.0074
28. Karon BS, Meeusen JW, Bryant SC. Impact of Glucose Meter Error on Glycemic Variability and Time in Target
Range During Glycemic Control after Cardiovascular Surgery. Journal of Diabetes Science and Technology.
2016;10,6:336-42.
29. Koyama K, Miyao H, Ikeda H, Fukuyama T, Harashima N, Tamura M, DuBois JA. et al. Evaluation of glucose
meter performance in an adult intensive care unit: Comparison of total analytical error versus ISO 15197:2003.
Critical Care Medicine. 2012;39(12):225		• Poster session presented at the meeting of the Society of Critical Care Medicine, Houston, TX, February 2012.

30. Malic A, Lyon ME, Lyon A W, Slingerland RJ, Fokkert M, Roman A, DuBois J A. et al. International multi-site
evaluation of a hospital POC blood glucose monitoring system in critically ill patients: Assessment of clinical risk
using insulin dosing error models. Poster session presented at the meeting of Werkgroep POCT van de Nationale
Commissie Klinische Biologie, Antwerp, Belgium, October 2014.
3

31. Mann EA, Mora AG, Pidcoke HF, Wolf SE, Wade CE. Glycemic Control in the Burn Intensive Care Unit: Focus on
the Role of Anemia in Glucose Measurement. Journal of Diabetes Science and Technology. 2009;3(6):1319-1329. doi:10.1177/193229680900300612
32. Mann EA, Pidcoke HF, Salinas J, Jones J, Holcomb JB, Wolf SE, Wade CE. Hematocrit effect outweighs othersources of glucometer error in critical care. Crit Care Med. 2007;35,12:A140.
		•P
 oster session presented at the meeting of the Society of Critical Care Medicine, Honolulu, HI, February 2008.

33. Rice MJ, Smith JL, Coursin DB. Glucose Measurement in the ICU: Regulatory Intersects Reality. Critical Care
Medicine. 2017;45(4):741-743. doi:10.1097/CCM.0000000000002274
34. Roman A, Claus M, Hanicq C, Piersoel V, Flament P, Stevens E, El Mahi T. et al. Comparative evaluation of
accuracy of three point-of-care glucometers in an adult ICU. Poster session presented at the meeting of the European
Society of Intensive Care Medicine, Vienna, Austria, October 2009.
35. Roman A, DuBois J A, Lyon M. Improved blood glucose levels achieved in ICU patients using hematocrit correctedglucose meter and blood gas analyzer results. Diabetes Technology & Therapeutics. 2011;13(2):247-48.
		•P
 oster session presented at the meeting of Advanced Technologies & Treatments for Diabetes, London, UK,
February 2011.

36. Roman A, Hanicq C, Flament P, El Mahi T, Stevens E, Vertongen F. Comparison of accuracy of a glucometer anda blood gas analyser in an adult ICU: The StatStrip Nova Biomedical fulfils TGC requirements. Critical Care.
2008;12(2):S65.
		•P
 oster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Barcelona, Spain, September 2008.

37. Roman A, Hanicq C, Flament P, El Mahi T, Vertongen F, Stevens E. Comparison of accuracy of three point-of-care
glucometers in an adult ICU. Poster session presented at the meeting of the department of Intensive Care Emergency
Medicine of Erasme University Hospital, Université Libre de Bruxelles, and the Belgian Society of Intensive Careand Emergency Medicine, Brussels, Belgium, March 2008.
38. Sartori D, Petrides A, Crutchfield C, Soto L, Berk L, Baxi A, Clarke W. et al. Comparison of the Nova Biomedical
StatStrip glucose meter to an IDMS hexokinase glucose method in oncology and renal insufficiency patients –Demonstration of utility in critically ill patients. Poster session presented at the meeting of the American Association
for Clinical Chemistry, Critical and Point-of-Care Testing Division, San Diego, CA, September 2014.
39. Scott R, Karon BS, Griesmann L, Bryant SC, DuBois JA, Shirey TL, Santrach PJ. et al. Comparison of four hospital
based glucose meter technologies for accuracy, precision, and interference encountered in critically ill patients.
Poster session presented at the meeting of the American Association for Clinical Chemistry, San Diego, CA, July
2007.
40. Seley JJ, Diaz R, Greene R. “Blood Glucose Meters in Icus. Controversies Surround Potential Restrictions on Their
Off-Label Use.” AJN The American Journal of Nursing. 2016;116,4:46-49.
41. Tuca A, Schober M-M, Korsatko S, Mader J, Bauer G, Smolle K-H, Wurzer P, Ellmerer M, Peiber T -R. Evaluationof three point of care glucose-meters in critically ill patients at a medical intensive care unit. Wiener klinische
Wochenschrift. 2014;126:S193-S193
		•P
 oster session presented at the Österreichischen Diabetes Gesellschaft [Austrian Diabetes Association] inSalzburg, Austria, November 2015.

42. Urimoto G, Kaneda T, Suzuki T. Is glucose measurement affected by the anesthetics? Poster session presented at themeeting of the American Society of Anesthesiology, Chicago, IL, October 2011.
43. Weidner MA, Flenniken M. Evaluation of point of care bedside glucose monitors for use in a specialty and transplant
hospital. Poster session presented at the meeting of the Diabetes Technology Society, San Diego, CA, October 2010.

4

Adult Clinical
44. Adlan NA, De Toress M, Barlas M, Hussain N, Owaidah TM. A method comparison study to compare major-market
point-of-care (POC) hospital glucose meters at King Faisal Specialist Hospital & Research Centre, Kingdom of
Saudi Arabia. Poster session presented at the meeting of the International Federation of Clinical Chemistry andLaboratory Medicine, Istanbul, Turkey, June 2014.
45. Al Humaidan N, Al Hayek A, Saleh J, Al Saeed A, Al Onazi A, Subki S. Comparison of three point of care meters
for accuracy, precision, and interferences at Prince Sultan Military Medical City. Poster session presented at themeeting of the International Federation of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey, June 2014.
46. Bigot E, Guérin M, Orsonneau J, Dudouet D. Influence of pO2 and hematocrit values on glycaemia measured bypoint of care testing (POCT) glucometers. Poster session presented at the meeting of the European Congress ofClinical Chemistry and Laboratory Medicine, Berlin, Germany, May 2011.
47. Božičević S, Lovrenčić MV, Biljak VR, Medvidović EP. Accuracy of the Nova StatStrip POCT glucose analyzer
for classification of fasting hyperglycaemia in high-risk individuals. Poster session presented at the meeting of theEuropean Congress of Clinical Chemistry and Laboratory Medicine, Milan, Italy, May 2013.
48. Caputo M, Saccani G, Fornalè M, Cenci B, Raffaelli A, Vita G, Schiesaro M. Esperienza di gestionedell’iperglicemia in pazienti ospedalizzati in area internistica [Experience of management of hyperglycemia in
hospitalized patients in internal medicine area]. Poster session presented at the meeting of the Associazione Medici
Endocrinologi and the American Association of Clinical Endocrinologists, Bari, Italy, November 2013.
49. Costa RF, Vivé EG, Badia AR, Corsa LL, Santos DP. Evaluación del glucómetro de uso hospitalario StatStrip (Nova)
y estudio comparativo en pacientes ingresados en la uci [Evaluation of hospital use StatStrip glucometer (Nova) andcomparative study in patients admitted to the ICU]. Poster session presented at the meeting of the Congreso Nacionaldel Laboratorio Clínico, Valencia, Spain, October 2009.
50. Cozzi L, Tartarotti C, Bonomo M, Bellavia G, Venturelli G, Marocchi A. An evaluation of the accuracy andreliability of a new generation point of care hospital glucose meter, that corrects for interference, in a general
hospital setting. Poster session presented at the meeting of the Italian Society of Clinical Biochemistry and ClinicalMolecular Biology, Rimini, Italy, October 2010.
51. DuBois, JA, Clarke W. “Point-of-Care Testing: An Evolving Approach to Direct Patient Care?” Point of Care.
2014;13,3:118-23.
52. DuBois, JA. The Role of POCT and Rapid Testing. Here Is an Overview of an Evolving Approach to Direct Patient
Care. Medical Laboratory Observer. 2013; 45(9):18-22.
53. Fokkert M, Slingerland RJ, Muller W, Lyon M, DuBois JA, Isbell TS, Malic A. Traceability bedside glucose
monitors: Traceability StatStrip bedside glucose monitor to ID-GCMS and concordance to the clinical laboratory IDGCMS aligned hexokinase method. Poster session presented at the meeting of Advanced Technologies & Treatments
for Diabetes, Vienna, Austria, February 2014.
54. Jday-Daly I, Augereau-Vacher C, De Curraize C, Fonfrède M, Lefevre G, Lacour B, Hennequin-Le Meur C. (2011).
Évaluation multicentrique de la fiabilité de cinq lecteurs de glycémie [Multicenter evaluation of the reliability of fiveblood glucose monitoring systems]. Annales de Biologie Clinique. 2011;69:55–61. doi:10.1684/abc.2010.0509
55. Koch CD, Wockenfus AM, Wangen TM, Sievers BA, Brown JK, Karon BS. Use of samples from indwelling venous
catheters for glucose meter testing. Clinical Chemistry. 2009;55(6):A100.
56. Kost GJ, Tran NK, Louie RF, Gentile NL, Abad VJ. Assessing the performance of handheld glucose testing forcritical care. Diabetes Technology & Therapeutics. 2008;10:65–71. doi:10.1089dia.2008.0049
57. Kyi M, Colman PG, Wraight PR, et al. Early Intervention for Diabetes in Medical and Surgical Inpatients Decreases
Hyperglycemia and Hospital-Acquired Infections: A Cluster Randomized Trial. Diabetes Care. 2019;42(5):832-840.
doi:10.2337/dc18-2342
58. Kyi M, Wraight PR, Rowan LM, Marley KA, Colman PG, Fourlanos S. Glucose alert system improves healthprofessional responses to adverse glycaemia and reduces the number of hyperglycaemic episodes in non-critical care
inpatients. Diabetic Medicine. 2018;35(6):816-823. doi:10.1111/dme.13623
5

59. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2009.
60. Ogawa T, Murakawa M, Matsuda A, Kanozawa K, Kato H, Hasegawa H, Mitarai T. Endogenous factors modified
by hemodialysis may interfere with the accuracy of blood glucose-measuring device. Hemodialysis International.
2012;16(2):266-273. doi:10.1111/j.1542-4758.2011.00640.x
61. Pidcoke HF, Wade CE, Mann EA, Salinas J, Cohee BM, Holcomb JB, Wolf SE. Anemia causes hypoglycemia in
intensive care unit patients due to error in single-channel glucometers: Methods of reducing patient risk. Critical
Care Medicine. 2010;38:471–476. doi:10.1097CCM.0b013e3181bc826f
62. Rensburg MA, Van S, Hudson C, Erasmus RT, Hoffman M. Evaluation and performance of StatStrip® glucose
meter. Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical andPoint-of-Care Testing Division, Prague, Czech Republic, October 2012.
63. Russell D, Bohnsack M. Evaluation and implementation of the Nova StatStrip bedside glucose monitor for patients
undergoing cardiopulmonary by-pass graft surgery (CABG). Point of Care. 2010;9(3):144-45
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Boston, MA, September 2010.

64. Scandinavian Evaluation of Laboratory Equipment for Primary Health Care [SKUP]. Nova StatStrip glucoseand ß-ketone hospital meter system: A report from an evaluation of glucose measurement organized by SKUP.
SKUP/2013/85. 2013.
65. Schöndorf T, Gunther-Wahl H, Steigerwald U, Langer C, Forst T, Pfützner A. A multi-site analytical assessment of a
new hospital POC glucose meter for accuracy, precision, correlation, and interferences encountered in hospitalized
patients. Poster session presented at the meeting of the Diabetes Technology Society, San Francisco, CA, November
2009.
66. Tran NK, Godwin ZR, Bockhold JC, Passerini AG, Cheng J, Ingemason M. Clinical impact of sample interference
on intensive insulin therapy in severely burned patients: A pilot study. Journal of Burn Care & Research.
2014:35;72–79. doi:10.1097/BCR.0b013e31829b3700
67. Tran NK, Godwin ZR, Bockhold JC, Passerini AG, Cheng J, Ingemason M. Clinical impact of sample interference
on intensive insulin therapy in severely burned patients: A pilot study. Poster session presented at the meeting of theAmerican Burn Association, Palm Springs, CA, April 2013.

Neonatal Critical and Intensive
68. Christoph J, Siegel J, Kattner E. Accuracy and reliability of a new generation glucose meter in a neonatal intensive
care unit. Poster session presented at the meeting of the International Congress of Pediatric Laboratory Medicine,
Berlin, Germany, May 2011.
69. Beardsall K, Thomson L, Elleri D, Dunger DB, Hovorka R. Feasibility of automated insulin delivery guided
by continuous glucose monitoring in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2020;105(3):279-284.
doi:10.1136/archdischild-2019-316871
70. Dalisay A, Seamonds B, Gong Y. Correlation of glucose methodologies-Nova Biomedical StatStrip versus
Radiometer ABL 90. Point of Care. 2014;13:70–71. doi:10.1097/POC.0000000000000018
71. Ivanov A. Comparison of hospital glucose meters in neonatal care unit. Poster session presented at the meeting of theAmerican Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, Prague, Czech Republic,
October 2012.
72. Malic A, Thomas A, Lyon ME, Slingerland R, Pearson J, DuBois JA. Multi-site evaluation of point of care glucose
meters in a neonatal intensive care unit. Poster session presented at the meeting of the 23rd International Symposium
on Neonatal Intensive Care, Milan, Italy, October 2008 and Nordic Congress in Clinical Chemistry, Oslo, Norway,
June 2010.

6

73. Nuntnarumit P, Chittamma A, Pongmee P, Tangnoo A, Goonthon S. Clinical performance of the new glucometerin the nursery and neonatal intensive care unit. Pediatrics International. 2011;53:218–223. doi:10.1111/j.1442200X.2010.03214.x
74. Raizman J, Henderson T, Shea J, Silverman S, Redmond S, Moore A, Dubois J, Adeli K. Impact of improved
glucose monitoring in the neonatal intensive care unit: An evaluation of analytical and clinical performance of thepoint of care Nova StatStrip. Clinical Biochemistry. 2014;47;1154. 10.1016/j.clinbiochem.2014.06.063.
		• Poster session presented at the meeting of American Association for Clinical Chemistry, Chicago, IL, 2014.

75. Slingerland R, Muller W, Fokkert M, Dollahmoursid R, Witteveen C, Munnikhuis R, Donald E. et al. The Nova
StatStrip® blood glucose meter evaluation: Hematocrit dependency, method comparison, interfering substances andneonatal samples. Point of Care. 2008;7(3).
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Barcelona, Spain, September 2008.

76. Stahl D, Herkner KR, Pollak A, Prusa AR. Performance of the Nova StatStrip point of care blood glucose meter in aneonatal intensive care unit. Point of Care. 2010;9(3):126-27.
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Boston, MA, September 2010.

77. Tendl K, Christoph J, Bohn A, Herkner KR, Pollack A, Prusa AR. Performance of Nova StatStrip point of care blood
glucose meter in a neonatal intensive care unit. Biochemia Medica. 2012;22,3:2.
78. Tendl K, Christoph J, Bohn A, Herkner KR, Pollack A, Prusa AR. Performance of Nova StatStrip point of care blood
glucose meter in a neonatal intensive care unit. Biochemia Medica. 2012;22,3:2.
		• Poster session presented at the meeting of the 2nd European Joint Congress of EFLM and UEMS, Dubrovnik,
Croatia, October 2012.

		• “Certificate of Award, Poster Award” at the meeting of the 2nd European Joint Congress of EFLM and UEMS,
Dubrovnik, Croatia, October 2012.

79. Thomas A, Sall S, Roberts C, Drayton M, DuBois J, Clampitt R. An evaluation of the analytical performance ofa new generation hospital based glucose meter and an assessment of its clinical reliability in a neonatal care unit.
Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Point-ofCare Testing Division, Barcelona, Spain, September 2008.
80. Thomas A, Sall S, Roberts C, Drayton M, DuBois J, Clampitt R. An evaluation of the analytical performance of a
new-generation hospital-based glucose meter and an assessment of its clinical reliability in a neonatal care unit. Pointof Care. 2009;8:68–73. doi:10.1097/POC.0b013e3181a4c94e
81. Tran NK, Godwin ZR, Steele AN, Wolf SE, Palmieri TL. Clinical Impact of Accurate Point-of-Care Glucose
Monitoring for Tight Glycemic Control in Severely Burned Children. Pediatric Critical Care Medicine.
2016;17(9):e406-e412. doi:10.1097/PCC.0000000000000877

Neonatal and Pediatric Clinical
82. Agus MS, Hirshberg E, Srinivasan V, et al. Design and rationale of Heart and Lung Failure - Pediatric INsulin
Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill
children. Contemporary Clinical Trials. 2017;53:178-187.
83. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL, et al. Tight glycemic control
versus standard care after pediatric cardiac surgery. New England Journal of Medicine. 2012;367(13):1208-1219.
doi:10.1056/NEJMoa1206044
84. Agus MS, Wypij D, Hirshberg EL, Srinivasan V, Faustino EV, Luckett PM, Alexander JL, et al. Tight Glycemic
Control in Critically Ill Children. New England Journal of Medicine. 2017;376(8):729-741. doi:10.1056/
NEJMoa1612348
785. Ba Y, Xu J, Yuan L, Zhu H, Yang Y, Lam MM, et al. Assessment of the performance of blood glucose monitoring
systems for monitoring dysglycaemia in neonatal patients. BMJ Paediatr Open. 2018;2(1):e000339. Published 2018
Oct 23. doi:10.1136/bmjpo-2018-000339
86. Dietzen DJ, Wilhite TR. Evaluation of the Nova StatStrip® blood glucose monitoring system in neonates. Poster
session presented at the meeting of the American Association for Clinical Chemistry, San Diego, CA, July 2007.
87. Fokkert M, Slingerland R. Performance of Nova StatStrip Glucose Meter in Newborns. Poster session presented
at the American Association for Clinical Chemistry, Critical and Point-of-Care Testing, San Diego, CA, September
2014.
88. Fokkert M, Slingerland, RJ. Performance of Nova StatStrip glucose meter in newborns. Poster session presented at
the meeting of the American Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, San
Diego, CA, September 2014.
89. Fokkert M, van Dijk J, Slingerland R. Performance of Nova StatStrip glucose meters in newborn. Poster session
presented at the meeting of the Diabetes Technology Society, Barcelona, Spain, November 2011.
90. Harris DL, Weston PJ, Harding JE. Lactate, rather than ketones, may provide alternative cerebral fuel in
hypoglycaemic newborns. Disease in Childhood. Fetal and Neonatal Edition. 2015;100(2):F161-F164. doi:10.1136/
archdischild-2014-306435
91. LeSourd S, Fortune L, Sanderson K, Wood B, Hall RW, Bornhorst J A. Comparative evaluation of three point-ofcare glucose meters with neonatal patient samples exhibiting varied hematocrit and triglyceride concentrations.
Poster session presented at the meeting of the American Association for Clinical Chemistry, Chicago, IL, July 2009.
92. Lockyer MG, Fu K, Edwards RM, Collymore L, Thomas J, Hill T, Devaraj S. Evaluation of the Nova
StatStrip glucometer in a pediatric hospital setting. Clinical Biochemistry. 2014;47(9):840-843. doi:10.1016/j.
clinbiochem.2014.01.004
93. Makaya T, Memmott A, Bustani P. Point-of-care glucose monitoring on the neonatal unit. Journal of Pediatrics andChild Health. 2012:48:342–346. doi:10.1111/j.1440-1754.2011.02253.x
94. Nangia S. Point of care estimation of blood glucose in neonates. Indian Pediatrics. 2012:49(8):612–613.
95. Ngerncham S, Piriyanimit S, Kolatat T, Inchgarm L, Kitsommart R, Jeerapaet K., et al. Validity of two point-of-care
glucometers in the diagnosis of neonatal hypoglycemia. Indian Pediatrics. 2012;49(8):621–625.
96. Platt M W. Lactate, Glucose and the Neonatal Brain: It’s Time to Challenge the Paradigm. Archives Of Disease inChildhood-Fetal and Neonatal Edition. 2015;100(2):F96-F97. doi:10.1136/archdischild-2014-307236
97. Raizman JE, Shea J, Daly CH, et al. Clinical impact of improved point-of-care glucose monitoring in neonatal
intensive care using Nova StatStrip: Evidence for improved accuracy, better sensitivity, and reduced test utilization.
Clinical Biochemistry. 2016;49(12):879-884. doi:10.1016/j.clinbiochem.2016.05.002
98. Thomas F, Signal M, Harris DL, Weston PJ, Harding JE, Shaw GM, Chase JG. Continuous glucose monitoring in
newborn infants: how do errors in calibration measurements affect detected hypoglycemia?. Journal of Diabetes
Science and Technology. 2014;8(3):543-550. doi:10.1177/1932296814524857
99. Wada Y, Nakamura T, Kaneshige M, et al. Evaluation of two glucose meters and interference corrections forscreening neonatal hypoglycemia. Pediatrics International. 2015;57(4):603-607. doi:10.1111/ped.12543
100.Wang L, Sievenpiper JL, de Souza RJ, Thomaz M, Blatz S, Grey V, Fusch C, Balion C. Hematocrit correction
does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia. Clinical Chemistry andLaboratory Medicine. 2013;51:1627–1635. doi:10.1515/cclm-2012-0436

Diabetes
101.Biljak VR, Božičević S, Lovrenčić MV, Car N. Performance of the StatStrip glucose meter in inpatient managementof diabetes mellitus. Diabetologia Croatica. 2010;39(3):105–110.

8

102.Božičević S, Biljak VR, Pavković P, Milic V, Lovrenčić MV. Performance of the StatStrip glucose hospital meter inpatients with diabetic nephropathy. Clinical Chemistry Laboratory Medicine. 2011;49(S1):874.
		• Poster session presented at the meeting of the European Congress of Clinical Chemistry and Laboratory
Medicine, Berlin, Germany, May 2011.

103.Lindquist KA, Chow K, West A, Pyle L, Isbell T S, DuBois J A, Nadeau K J. et al. The StatStrip® glucose monitor
is suitable for use during hyperinsulinemic euglycemic clamps in a pediatric population. Diabetes Technology &Therapeutics. 2014;16,5:298-302.
		• Poster session presented at the meeting of Advanced Technologies & Treatments for Diabetes, Vienna, Austria,
February 2014.

104.Lovrenčić MV, Biljak RV, Božičević S, Car N. Performance of the StatStrip POCT analyzer in detecting
hypoglycaemic episodes in diabetic patients. Biochemia Medica. 2012;22(3):A84
		• Poster session presented at the meeting of the European Joint Congress, Dubrovnik, Croatia, October 2012.

105.Lovrenčić MV, Biljak RV, Pape-Medvidović E, Božičević S. Beyond monitoring: Validation of the StatStrip glucose
meter as a diagnostic tool for diabetes mellitus. Poster session presented at the meeting of Advanced Technologies &Treatments for Diabetes, Paris, France, February 2013.
106.Lovrenčić MV, Božičević S, Biljak VR, Marković I, Prašek M. Diagnosing gestational diabetes mellitus: A newchallenging task for the Nova-StatStrip POC glucose analyzer. Poster session presented at the meeting of theInternational Federation of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey, June 2014.
107.Petersmann A, Kallner A, Blaurock M, Nauck M. Glucose measurements in diagnosis and monitoring of patientswith diabetes mellitus: Comparison of assay performance of patient near testing and core-lab methods. Poster session
presented at the meeting of the German Society for Clinical Chemistry and Laboratory Medicine, Dresden, Germany,
October 2013.
108.Rabiee A, Magruder JT, Grant C, Salas-Carrillo R, Gillette A, DuBois J, Elahi D. et al. Accuracy and reliability of
the Nova StatStrip® glucose meter for real-time blood glucose determinations during glucose clamp studies. Journalof Diabetes Science and Technology. 2010;4(5):1195–1201.
109.Rensburg MA, Hudson C, Eramus RT. Evaluation and performance of StatStrip glucose meter. Point of Care.
2014;13:137–141. doi:10.1097/POC.0000000000000037
110. Rice MJ, Coursin DB. Glucose Meters: Here Today, Gone Tomorrow?. Critical Care Medicine.
2016;44(2):e97-e100. doi:10.1097/CCM.0000000000001389
111. Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Pape-Medvidović E, Ljubić S. Validation of point-of-care
glucose testing for diagnosis of type 2 diabetes. International Journal of Endocrinology. 2013;2013:206309.
doi:10.1155/2013/206309
112. Yamashita K, Shirai H, Kuwa K. Comparative analysis of capillary whole blood by 2 blood glucose monitoring
systems (BGMS) with venous plasma hexokinase glucose results in patients undergoing an oral glucose tolerance
test (OGTT). Poster session presented at the meeting of the American Association for Clinical Chemistry, Criticaland Point-of-Care Testing Division, San Diego, CA, September 2014.

Dialysis113. Bewley B, O’Rahilly S, Tassell R. Improved POC meter accuracy for monitoring and managing glucose levels
in dialysis patients. Poster session presented at the meeting of the European Congress of Clinical Chemistry andLaboratory Medicine, Innsbruck, Austria, June 2009.
114. Bewley B, O’Rahilly S, Tassell R, DuBois J, Donald E. Evaluation of the analytical specificity and clinicalapplication of a new generation hospital-based glucose meter in a dialysis setting. Point of Care. 2009;8:61–67.
doi:10.1097/POC.0b13e3181a4c4f4

9

115. Bewley B, O’Rahilly S, Tassell R, DuBois J, Donald E. An evaluation of analytical specificity and clinicalapplication of a new generation hospital based glucose meter in a dialysis setting. Poster session presented at themeeting of the American Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, Barcelona,
Spain, September 2008.
116. Galović R, Baršić I, Rogić D. Evaluation of maltose interference on hospital-based glucose meters and their accuracy
in a peritoneal dialysis context. Poster session presented at the meeting of the International Federation of Clinical
Chemistry and Laboratory Medicine, Istanbul, Turkey, June 2014.
117. Ogawa T, Murakawa M, Matsuda A, Kanozawa K, Kato H, Hasegawa H, Mitarai T. Endogenous factors modified
by hemodialysis may interfere with the accuracy of blood glucose measuring device. Hemodialysis International.
2012;16:266–273. doi:10.1111/j.1542-4758.2011.00640.x
118. Perera NJ, Stewart PM, Williams PF, Chua EL, Yue DK, Twigg SM. (2011). The danger of using inappropriate
point-of-care glucose meters in patients on icodextrin dialysis. Diabetes Medicine. 2011;28:1272–1276. doi:10.1111/
j.1464-5491.2011.03362.x

Analytical
119. Adlan NA, De Toress M, Barlas M, Hussain N, Owaidah TM. Analytical performance study to review the effects ofspecific substances interference on different glucose meters at King Faisal Hospital and Research Centre, Riyadh/
Saudi Arabia. Poster session presented at the meeting of the International Federation of Clinical Chemistry andLaboratory Medicine, Istanbul, Turkey, June 2014.
120.Ahmad E. A method comparison and analytical performance study to assess the performance of two point-of-care
glucose meters against the laboratory reference method. Poster session presented at the meeting of the American
Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, San Diego, CA, September 2014.
121.Bewley B, O’Rahilly S, Tassell R, DuBois J, Clampitt R. Comparison of four hospital based glucose meter
technologies for accuracy, precision and interferences encountered in hospitalized patients. Poster session presented
the meeting of the European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands,
June 2007.
122.Brouwer N, Tegelaers FP. The effect of interfering substances in point of care glucose measurements. Clinical
Chemistry Laboratory Medicine. 2011;49.
123.Brouwer N, Tegelaers FP. Vergelijking van vier point of care glucose meters met de laboratoriummethode: Correlatie
en interferenties [Comparison of four point-of-care blood glucose meters with the laboratory method: Correlationand interferences]. Ned Tijdschr Klin Chem Labgeneesk. 2011;36(4):239–242.
		• Poster session presented at the meeting of the European Congress of Clinical Chemistry and Laboratory
Medicine, Berlin, Germany, May 2011.

124.Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, Mosca A. “Comparative Performance
Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside.” Journal of
Diabetes Science and Technology. 2015;9,2:268-77
125.Chittamma, A, DuBois J A, Shirey T, Heinz M, Santanirand P, Chaichanajarernkul U, Vanavanan S. Performanceof StatStrip® meter. Poster session presented at the meeting of the European Congress of Clinical Chemistry andLaboratory Medicine, Amsterdam, Netherlands, June 2007.
126.Cho J, Ahn S, Yim J, Cheon Y, Jeong SH, Lee S-G, Kim J-H. Influence of Vitamin C and Maltose on the
Accuracy of Three Models of Glucose Meters. Annals of Laboratory Medicine. 2016;36(3):271-274. doi:10.3343/
alm.2016.36.3.271
127.Christoph J, Malic A, Sander J, Kattner E. Galactose-interference on POCT glucose analysis. Pediatric Research.
2010;68:517. doi:10.1203/00006450-201011001-01042

10

128.Christoph J, Sander J, Kattner E. Galactose interference on POCT glucose analysis. Poster session presented at themeeting of the American Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, Boston,
MA, September 2010.
129.Clarke W, DuBois JA. “Potential Conflict between Analytical Performance Standards and Clinical Safety andEfficacy of Whole Blood Glucose Measurement Devices [Editorial].” Point of Care. 2014;13,3:107-11.
130.Clausen D. Haematocrit interference in blood glucose monitors, a real problem in acute hospital settings. Poster
session presented at the meeting of the Australasian Association of Clinical Biochemists, Brisbane, Australia,
September 2009.
131.Cruthis S. Development and use of a methodology for the evaluation and implementation of POCT devices. Poster
session presented at the meeting of the American Association for Clinical Chemistry, Critical and Point-of-CareTesting Division, Boston, MA, September 2010.
132.de Mol P, Krabbe H G, de Vries S T, Fokkert M J, Dikkeschei B D, Rienks R, Bilo H J. et al. Accuracy of handheld
blood glucose meters at high altitude. PLOS ONE. 2010;5:e15485. doi:10.1371/journal.pone.0015485
133.Diagnostics, Roche. “Accu-Chek Inform II: Test Strips and 1 Code Key [Package Insert].” Roche Diagnostics. 2013.
134.DuBois, J A, Karon B S, Greismann L, Scott R, Santrach P J, Dietzen DJ, Wilhite T R, et al. A Multi-Site
Comparison of Bedside Glucose Meter Technologies for Accuracy, Precision, Correlation, and Interferences
Encountered in Hospitalized Patients. Poster session presented at the European Association for the Study ofDiabetes, Amsterdam, Netherlands, September 2007.
135.Ekhlaspour L, Mondesir D, Lautsch N, et al. Comparative Accuracy of 17 Point-of-Care Glucose Meters. Journal of
Diabetes Science and Technology. 2017;11(3):558-566. doi:10.1177/1932296816672237
136.Friederichs B, Younessi-Sinaki G, Aust P, DuBois J A, Wahl H G. Analytical performance of an interference-resistantglucose meter.” Point of Care. 2008;7:3.
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Barcelona, Spain, September 2008.

137.Gijzen K, Moolenaar D, Weusten J, Pluim H, Demir A. Is there a suitable point-of-care glucose meter for tightglycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit. Clinical
Chemistry and Laboratory Medicine. 2012;50,11:1985-1992. doi:10.1515/cclm-2012-0104
138.Goudable J, Pollet J, DuBois J A. Inexactitude des lecteurs de glycémie. Correction automatique pour les variations
de l’hématocrite et la presence d’interférents exogènes [Inaccuracy of glucose meters. Automatic correction forhematocrit variations and the presence of exogenous interfering components]. Annales de Biologie Clinique.
2008:66:647–655. doi:10.1684/abc.2008.0279
139.Havelková E, Dušková D, Jabor A, Franeková J, Komínková M. Testování glukometrů a jejich porovnání [Testingblood glucose meters and their comparison]. FONS. 2008;18(1):36–45.
140.Herkner K, Schneider U, Rabold T, Tomasoni R. Reliability of glucose meters in hospitals in Austria. Poster session
presented at the meeting of the European Congress of Clinical Chemistry and Laboratory Medicine, Innsbruck,
Austria, June 2009.
141.Holtzinger C, Szelag E, DuBois J A, Shirey T L, Presti S. Evaluation of a new POCT bedside glucose meter and strip
with hematocrit and interference corrections. Point of Care. 2008;7:1–6. doi:10.1097/POC.0b013e318162f4da
142.Howes M, Steele A N, Godwin Z, Tran N K. Comparison of glucose meter performance against three laboratoryreference methods: An extensive evaluation. Poster session presented at the meeting of the American Association for
Clinical Chemistry, Critical and Point-of-Care Testing Division, San Diego, CA, September 2014.
143.Isbell TS. A Review of Compliant Glucose Poct Options. MedicalLab Management. 2016:5,1:2-7.
144.Isgrò MA, Morelli R, Zuppi C, Scribano D. Does the analytical error in blood glucose monitoring system correlate
to clinical risk? Poster session presented at the meeting of the International Federation of Clinical Chemistry andLaboratory Medicine, Istanbul, Turkey, June 2014.
11

145.Isgrò MA, Morelli R, Zuppi C, Scribano D. Specificity Assessment of Currently Available Glucose Meters. Diabetes
Technology & Therapeutics. 2014;16,1:A-2.
146.Isgrò MA, Morelli R, Zuppi C, Scribano D. Specificity assessment of currently available glucose meters. Poster
session presented at the meeting of Advanced Technologies & Treatments for Diabetes, Vienna, Austria, February
2013.
147.Jacobs J, Fokkert M, Slingerland R, De Schrijver P, Van Hoovels L. A further cautionary tale for interpretation of
external quality assurance results (EQA): Commutability of EQA materials for point-of-care glucose meters. Clinica
Chimica Acta. 2016;462:146-147. doi:10.1016/j.cca.2016.09.012
148.Kaczmarek E, Guerra E, Mosca A, Mastrantonio F, Lucarelli F, Valgimigl F, Ceriotti F. Comparative Assessment of
the Performance of the StatStrip Point-of-Care Testing Device for the Measurement of Ketone Bodies. Poster session
presented at Euromedlab, Milan, Italy, May 2013.
149.Karon BS, Griesman L, Scott R, Bryant S C, DuBois J A, Shirey T L, Santrach P J. et al. Evaluation of the impactof hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technology &Therapeutics. 2008;10:111–120. doi:10.1089/dia.2007.0257
150.Karon BS. Glucose meter accuracy in different applications. Point of Care. 2017;16:(1)5-8.
151.Kelly BN, Haverstick D M, Bruns D E. Interference in a glucose dehydrogenase based glucose meter revisited[Letter to the editor]. Clinica Chimica Acta. 2012;413:829–830. doi:10.1016/jcca.2012.01.023
152.Kergueno J, Sauvageot V, Allary J, Chettab L, Hamada S, Harrois A, Ferrari F, Raux M, Groupe TRAUMABASE.
“Agrément Entre Les Lactacidémies Mesurées Par Méthode Portable Et Par Méthode Conventionnelle À L’arrivée
D’un Traumatisé [Agreement between the Measured Lactate Portable Method and Method Conventional to the
Arrival of a Traumatized].” Poster session presented at the SFAR Le Congrès 2013 (Société Française d’Anesthesie
et de Réanimation) [French Society of Anesthesia and Reanimation Congress 2013], Paris, France, September 2013.
153.Koyama K, Miyao H, Ikeda H, Fukuyama T, Harashima N, Tamura M, DuBois J A. et al. Glucose meter total
analytical error associated with the hematocrit levels commonly seen in an adult intensive care unit. Critical Care
Medicine. 2012;39(12):222.
		• Poster session presented at the meeting of the Society of Critical Care Medicine, Houston, TX, February 2012.

154.Koyama K., Miyao H, Ikeda H, Fukuyama T, Harashima N, Tamura M, DuBois, JA. et al. Estimates of glucose
meter total analytical error associated with chemical interferences commonly seen in an adult intensive care unit.
Critical Care Medicine. 2012;39(12):225.
		• Poster session presented at the meeting of the Society of Critical Care Medicine, Houston, TX, February 2012.

155.Kyi M, Colman PG, Rowan LM, Marley KA, Wraight PR, Fourlanos S. Glucometric Benchmarking in an Australian
Hospital Enabled by Networked Glucose Meter Technology. The Medical Journal of Australia. 2019;211,4:175-80.
156.Lou A, Robinson V. Evaluation of Lifescan SureStep Flexx (Lifescan), Roche AccuCheck Inform II(Roche) and Nova Biomedical StatStrip glucose meters. Clinical Biochemistry. 2010;43:776. doi:10.1016/j.
clinbiochem.2010.04.009
157.Lv H, Zhang G, Kang X, Yuan H, Lv Y, Wang W, Randall R. Factors interfering with the accuracy of five blood
glucose meters used in Chinese hospitals. Journal of Clinical Laboratory Analysis. 2013;27:354–366. doi:10.1002/
jcla.21611
158.Lyon ME, Baskin LB, Braakman S, Presti S, DuBois JA, Shirey T. Evaluation of a glucose meter with negligible
hematocrit or chemical interference. Poster session presented at the meeting of the American Association for Clinical
Chemistry, Washington, D.C., July 2008.
159.Lyon ME, Baskin LB, Braakman S, Presti S, DuBois JA, Shirey T. Interference studies with two hospital-grade
and two home-grade glucose meters. Diabetes Technology & Therapeutics. 2009;11(10):641–647. doi:10.1089/
dia.2009.0035

12

160.Lyon ME, DuBois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose
meters contributed by hematocrit, maltose, and ascorbate. Journal of Diabetes Science and Technology.
2010;4(6);1479–1494.
161.Lyon ME, DuBois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose
meters contributed by hematocrit, maltose, and ascorbate. Poster session presented at the meeting of the American
Association for Clinical Chemistry, Critical and Point-of Care Testing Division, Boston, MA, September 2010.
162.Lyon ME, DuBois JA, Slingerland RJ, Lyon AW. Impact of the comparative method on the outcome of a glucose
meter evaluation. Poster session presented at the meeting of Advanced Technologies & Treatments for Diabetes,
Vienna, Austria, February 2014.
163.Lyon ME, Fokkert M, DuBois JA, Slingerland R. A mathematical model to determine the impact of non-glucose
carbohydrates on the performance of blood gas analyzer glucose methods. Poster session presented at the meeting ofAdvanced Technologies & Treatments for Diabetes, Vienna, Austria, February 2014.
164.Lyon ME, Gray D, Baskin LB, DuBois JA, Lyon AW. A mathematical model to assess the influence ofhematocrit on point of care glucose meter performance. Clinical Biochemistry. 2010;43:905–909. doi:10.1016/j.
clinbiochem.2010.03.008
165.Lyon ME, Gray D, Baskin LB, DuBois JA, Lyon AW. Impact of patient hematocrit on glucose meter performance.
Poster session presented at the meeting of the Diabetes Technology Society. San Francisco, CA, November 2009.
166.Lyon ME, Isbell TS, DuBois JA, Fokkert M, Slingerland RJ, Lyon A W. A mathematical model to determine theimpact of low concentrations of galactose on the performance of glucose meters. Poster session presented at themeeting of Advanced Technologies & Treatments for Diabetes, Vienna, Austria, February 2014.
167.Lyon ME, Lyon OAS, Tran NK, DuBois JA, Lyon AW. An insulin-dose error assessment grid: A new tool to evaluate
glucose meter performance. Clinical Biochemistry. 2019;70:30-33. doi:10.1016/j.clinbiochem.2019.06.001
168.Mackay L, Clark T, Wijeratne N G. Blood glucose measurements in neonates: The importance of getting it right.
Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Point-ofCare Testing Division, San Diego, CA, September 2014.
169.Mann EA, Pidcoke HF, Salinas J, Wolf SE, Wade CE, Holcomb J B. Hematocrit causes the most significant
error in point of care glucometers [Letter to the editor]. Critical Care Medicine. 2009;37:1530. doi:10.1097/
CCM.0b013e31819d2e8a
170.Mohn B. Evaluation of the Nova Biomedical StatStrip glucose meter. New Zealand Journal of Medical Laboratory
Science. 2010;64(1):18–21.
171.Musholt P, Scherer S, Schöndorf T, Younessi A, DuBois J, Aust P, Pfützner A. et al. Genauigkeit desblutzuckermesssystems StatStrip im vergleich zu anderen messsystemen und zu einer standard-labormethode[Comparison of the accuracy of the blood glucose monitoring system StatStrip compared to other measuring systems
and to a standard laboratory method]. Diabetology and Metabolism. 2008;3-A284. DOI: 10.1055/s-2008-1076431
		• Poster session presented at the meeting of the German Diabetes Association, Munich, Germany, April 2008.

172.Nakadate Y, Sato H, Roque P, et al. Accuracy of blood glucose measurements using the NOVA StatStrip®
glucometer during cardiac surgery: a prospective observational study. Précision des mesures de la glycémie prises
avec le glucomètre StatStrip® de NOVA pendant une chirurgie cardiaque : une étude observationnelle prospective.
Canadian Journal of Anesthesia. 2019;66(8):943-952. doi:10.1007/s12630-019-01350-7
173.Nova’s Diabetes Care Products Held Not To Infringe Roche’s Claims. Ropes & Grey LLP. https://www.ropesgray.
com/en/newsroom/news/2010/07/novas-diabetes-care-products-held-not-to-infringe-roches-claims. July 30, 2010.
174.Pfützner A, Harzer O, Musholt PB, Scherer S, Löbig M, Forst T. Performance of blood glucose measurement
systems influenced by interfering substances. Diabetes Stoffwechsel und Herz. 2009;18, 387–392.
175.Pfützner A, Musholt P, Scherer S, Löbig M, Younessi A, DuBois J, … Forst T. Interference of hematocrit andmaltose plasma concentrations on the accuracy of five different blood glucose measurement systems. 2008.
13176.Pollet J, Goudable J, DuBois J A. Evaluation d’un nouveau lecteur de glycémie intégrant une correction automatiquede l’hématocrite [Evaluation of a new blood glucose meter incorporating an automatic correction of the hematocrit].
Spectra Biologie. 2008;64(Janvier – Février – Mars):73–76.
177.Ramljak S, Lock JP, Schipper C, Musholt PB, Forst T, Pfützner A. “Hematocrit Interference Is a Common
Phenomenon in Many Devices for Glucose Self-Measurement.” Poster session presented at the Advanced
Technologies & Treatments for Diabetes, Barcelona, Spain, February 2012.
178.Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. Accuracy evaluation of a new glucometer with
automated hematocrit measurement and correction. Clinica Chimica Acta. 2005 Jun;356(1-2):178-83. doi:10.1016/j.
cccn.2005.01.027
179.Robinson CS, Sharp P. Tighter accuracy standards within point-of-care blood glucose monitoring: how six
commonly used systems compare. Journal of Diabetes Science and Technology. 2012;6(3):547-554. Published 2012
May 1. doi:10.1177/193229681200600309
180.Schöndorf T, Forst T, Pfützner A. Interferents in glucose determination do not influence the hospital POC glucose
meter StatStrip in accuracy and precision of blood glucose measurement. Poster session presented at the meeting of
the European Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany, May 2011.
181.Schöndorf, T., P. Musholt, S. Scherer, M. Löbig, A. Younessi, J. Dubois, P. Aust, T. Forst, and A. Pfützner. “Das
Blutzuckermesssystem StatStrip Ist Nicht Empfindlich Für Interferenzen Durch Hämatokrit Oder Andere Bekannte
Störsubstanzen [the Blood Glucose Monitoring System StatStrip Is Not Sensitive to Hematocrit or Other Known
Interfering Substances].” Diabetologie und Stoffwechsel. 2008;3,S1:A42.
182.Simpson PA, Tirimacco R, Tideman PA. Evaluation of four hospital glucose meters.
		• Poster session presented at the meeting of the Australasian Association of Clinical Biochemists, Brisbane,
Australia, September 2009.

183.Slowinska-Solnica K, Kapusta M, Gawlik K, Pawlica D, Grudzien U, Solnica B. Analytical evaluation of the
StatStrip Xpress and the StatStrip hospital meters as a glucose monitoring system in a SMBG and POCT. Biochimica
Clinica. 2013;37(SS):S694.
184.Smith G, McNeil-Szostak E, Ocrah G, Rowland S, Vargas R. RGH’s method for evaluation and implementation ofpoint of care bedside glucose (POCTG) monitoring. Point of Care. 2010;9(3):1.
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Boston, MA, September 2010.

185.Smith JL, Rice MJ. Why Have So Many Intravascular Glucose Monitoring Devices Failed?. Journal of Diabetes
Science and Technology. 2015;9(4):782-791. doi:10.1177/1932296815587013
186.StatStrip Glucose FDA 510K Pre-Market Notification K181043. https://www.accessdata.fda.gov/cdrh_docs/reviews/
K181043.pdf.
187.Steele AN, Godwin Z, Howes M, Tran NK. Extensive evaluation of sample interference on point-of-care glucose
meters. Poster session presented at the meeting of the International Federation of Clinical Chemistry and Laboratory
Medicine, Istanbul, Turkey, June 2014.
188.Stout PJ, Peled N, Erickson BJ, Hilgers ME, Racchini JR, Hoegh TB. Comparison of glucose levels in dermalinterstitial fluid and finger capillary blood. Diabetes Technology & Therapeutics. 2001;3(1):81-90. doi:10.1089/1520
91501750220046
189.Thomas A, Sall S, Blount N, Perkins M, Roberts C, Williams R. Four step validation procedure for evaluating POCT
meters. Point of Care. 2010;9(3):1.
		• Poster session presented at the meeting of the American Association for Clinical Chemistry, Critical and Pointof-Care Testing Division, Boston, MA September 2010.

190.Tirimacco R, Siew L, Simpson PA, Cowley PJ, Tideman PA. Understanding the hematocrit effect on glucose testing
using popular point-of-care testing devices. Point of Care. 201;13:128-131. doi:10.1097/POC.0000000000000040
14191.Tran NK, Steele AN, Godwin Z, Howes M. Extensive evaluation of hematocrit on point-of-care glucose meters.
Poster session presented at the meeting of the International Federation of Clinical Chemistry and Laboratory
Medicine, Istanbul, Turkey, June 2014.
192.Vanavanan S, Santanirand P, Chaichanajarernkul U, Chittamma A, DuBois JA, Shirey T, Heinz M. Performanceof a new interference-resistant glucose meter. Clinical Biochemistry. 2010;43(1-2):186–192. doi:10.1016/j.
clinbiochem.2009.09.010
193.Wang Y. Comparison of Poc Blood Glucose Monitoring Systems (Bgms) Performance Idms Aligned Reference
Methods: An Extensive Evaluation. 2015 Diabetes Technology Meeting Abstracts, Journal of Diabetes Science andTechnology. 2016;10(2):476-611. doi:10.1177/1932296816639698
194.Wang Y. Development of a Primary Idms Traceable Reference Procedure in China for Blood Glucose Testing a Key
Step for Evaluating Poc Glucose Methodologies. 2015 Diabetes Technology Meeting Abstracts, Journal of Diabetes
Science and Technology. 2016;10(2):476-611. doi:10.1177/1932296816639698
195.Zhu H, Xu J, Qiu W, DuBois JA, Xu J. NIST calibration alignment is essential when selecting a laboratory reference
method for evaluating POC Blood Glucose Monitoring Systems. Clinica Chimica Acta. 2019;488:172-173.
doi:10.1016/j.cca.2018.11.012

15

Content current as of revision date.

354G V2 US 11/10/23